These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 690425)

  • 61. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M
    J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibodies to influenza A/swine-like viruses (Hsw1N1) in human sera: antigenic stimulation and changes in antibody status.
    Pyhälä R
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):373-8. PubMed ID: 998257
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Surveillance of the antibody status to current influenza strains in the Norwegian population. 2: Antibodies to the A/USSR/90/77 (H1N1) virus in various age groups after the second epidemic wave.
    Haaheim LR
    NIPH Ann; 1980 May; 3(1):49-56. PubMed ID: 7454125
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pandemic influenza and the swine influenza virus.
    Hattwick MA; O'Brien RJ; Hoke CH; Dowdle WR
    Bull Pan Am Health Organ; 1976; 10(4):283-92. PubMed ID: 799946
    [No Abstract]   [Full Text] [Related]  

  • 66. Influenza in Melbourne, 1982. Epidemiology and virology.
    Kennett ML; Downie J; White J; Ward BK; Mutton KJ; Irving LG; Birch CJ; Rodger SM
    Med J Aust; 1984 Jul; 141(2):89-92. PubMed ID: 6377029
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Seroepidemiologic study on influenza A (H1N1) virus infection among school children after an "antigenic shift" from A (H3N2) to a (H1N1) in Kukuoka of southern Japan in 1978.
    Tokugawa K; Ueda K; Sakoh M; Yoshikawa H; Nonaka S
    Pediatr Infect Dis J; 1987 Aug; 6(8):761-2. PubMed ID: 3670940
    [No Abstract]   [Full Text] [Related]  

  • 68. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L; Rudnicka H
    Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 70. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.
    Guiomar R; Pereira da Silva S; Conde P; Cristóvão P; Maia AC; Pechirra P; Rodrigues AP; Nunes B; ; Milho L; Coelho AP; Fernandes A; Caseiro P; Rodrigues F; Correia L; Pereira-Vaz J; Almeida S; Branquinho P; Côrte-Real R; Viseu R; Peres MJ; Sanches R; Dantas F; Freitas L; Andrade G; Maurílio M; Caldeira F; Cabral Veloso R; Mota-Vieira L; Soares M; Couto AR; Bruges-Armas J; Pinto RM; Sobrinho Simões J; Costa MDR; Guimarães JT; Martins L; Cunha M
    Vaccine; 2017 Apr; 35(16):2092-2099. PubMed ID: 28318771
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Neuraminidase-Inhibiting Antibodies to Avian Influenza Virus Subtypes in Human Sera (author's transl)].
    Zilske E; Sinnecker R; Sinnecker H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):34-41. PubMed ID: 7198360
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
    Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
    PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Changes in the antibody status of a population following epidemic infection by influenza virus A2-Hong Kong-1-68.
    Machin SJ; Potter CW; Oxford JS
    J Hyg (Lond); 1970 Sep; 68(3):497-504. PubMed ID: 5272348
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Comparative analysis of the antigenic composition of the hemagglutinins of influenza viruses A/England/42/72, A/Port Chalmers/73 and A/USSR/053/74].
    Kosiakov PN; Rovnova ZI; Isaeva EI; Platonova AL; Pankratov VS
    Vopr Virusol; 1976; (3):301-8. PubMed ID: 62455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epizootics of respiratory tract disease in swine in Belgium due to H3N2 influenza virus and experimental reproduction of disease.
    Haesebrouck F; Biront P; Pensaert MB; Leunen J
    Am J Vet Res; 1985 Sep; 46(9):1926-8. PubMed ID: 2413789
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Characteristics of the causative agents of the influenza A (H3N2) epidemic in Leningrad in 1983].
    Ivanova NA; Kudriavtseva VK; Nevedomskaia GN; Kramskaia TA; Taros LIu
    Vopr Virusol; 1984; 29(3):286-90. PubMed ID: 6235673
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains.
    Velazco JG; Couch RB; Six HR; Glezen WP
    Bull World Health Organ; 1983; 61(2):345-52. PubMed ID: 6190585
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Demonstration of antibodies to both hemagglutinin and neuraminidase antigens of H3N2 influenza A virus in domestic dogs.
    Kilbourne ED; Kehoe JM
    Intervirology; 1975-1976; 6(4-5):315-8. PubMed ID: 1235862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.